TrialCancer science2016

Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.

Yoshihiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.